LifeScience Vaccines
NEC Bio Therapeutics and AGC Biologics Partner to Enhance Production of Personalized Cancer Vaccine
NEC Bio Therapeutics and AGC Biologics have announced a partnership to advance the production of NECVAX-NEO1, an orally delivered, bacteria-based D...
August 08, 2024 | News
Pfizer Announces Launch of Bivalent RSV Vaccine in Hong Kong and Macau
Pfizer Inc. has announced the availability of its bivalent RSV prefusion F (RSVpreF) vaccine in Hong Kong this month. Approved by health authorities in Hon...
July 19, 2024 | News
Indian Immunologicals Donates 10,000 Doses of Anti-Rabies Vaccine to Vulnerable Communities in Vietnam
Indian Immunologicals Ltd (IIL), led by its Chairman Dr. Meenesh Shah and Managing Director Dr. K. Anand Kumar, has generously donated 10,000 doses of its ...
July 17, 2024 | News
Sabin Vaccine Institute Launches Phase 2 Trial for Sudan Ebolavirus Vaccine in Uganda
Sabin Vaccine Institute launched a Phase 2 clinical trial for its vaccine against Sudan ebolavirus, with healthy volunteers receiving the single-...
July 16, 2024 | News
Merck and Afrigen Partner in South Africa to Develop mRNA Platform Technology, Boosting Global Vaccine Access
Aim of the collaboration is to develop mRNA platform technology, scale up and troubleshoot challenges in mRNA process optimization Contributes to expand...
July 05, 2024 | News
PharmaJet’s Needle-Free Tropis® System to Drive House-to-House Polio Immunization Campaign in Somalia
PharmaJet®, a company dedicated to enhancing the performance and outcomes of injectables through innovative delivery systems, today announced that thei...
June 28, 2024 | News
Pfizer and BioNTech's Omicron JN.1 COVID-19 Vaccine Receives CHMP Recommendation
The updated COVID-19 vaccine is tailored to the Omicron JN.1 lineage of SARS-CoV-2 and is recommended for individuals 6 months of age and older Re...
June 28, 2024 | News
ILiAD Biotechnologies Selects Emmes Group for Global Phase III Trials of BPZE1 Pertussis Vaccine
Multiple Phase III studies are expected to be conducted across North America, Central and South America, UK and other global clinical sites VaxTrials, p...
June 25, 2024 | News
FDA Approves GSK's AREXVY Vaccine for High-Risk Adults Aged 50-59
Over 13 million US adults aged 50-59 years have a medical condition that increases their risk of severe RSV outcomes1 Clinical development program conti...
June 10, 2024 | News
Thermo Fisher Scientific Opens Cutting-Edge Ultra-Cold Facility in EU to Boost Advanced Therapy Development
Thermo Fisher Scientific Inc., the world leader in serving science, has opened a new clinical and commercial ultra-cold facility in the EU, expanding its c...
June 03, 2024 | News
Serum Institute of India Acquires 20% Stake in IntegriMedical to Accelerate Development of Needle-Free Injection Technology
- With this investment, SII will acquire 20% stake in IntegriMedical - ...
May 20, 2024 | News
Overcoming Vaccine Access Challenges in Asia Pacific: Perspectives from DKSH's Reuben Ong
Timely access to vaccines is crucial for public health, especially in regions with diverse regulatory landscapes like the Asia Pacific. Bio...
May 17, 2024 | Interview
HSA Approves Arexvy, World's First RSV Vaccine, for Older Adults in Singapore
The Health Sciences Authority (HSA) of Singapore has approved Arexvy (recombinant, AS01E adjuvanted) for active immunisation to prevent lower respiratory t...
May 16, 2024 | News
WestGene Achieves FDA Approval for World's First EB Virus-Related mRNA Cancer Vaccine, WGc-043
WestGene, a biotech company dedicated to mRNA technology, announces a historic milestone with the FDA IND approval of its mRNA therapeutic cancer vaccine, ...
May 13, 2024 | News
Most Read
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
